Autologous EBV-specific cytotoxic T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous EBV-specific cytotoxic T lymphocytes, covering 2025-02-19 to 2025-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis [Phase 1]